Table 2.
Exposures | Model 1
a
Crude OR (95% CI) |
Model 2
b
Adjusted OR (95% CI) |
Model 3
c
Adjusted OR (95% CI) |
---|---|---|---|
NLR | |||
Q1 | Ref. | Ref. | Ref. |
Q2 | 1.123 (0.775-1.627) | 1.055 (0.705-1.579) | 1.038 (0.690-1.562) |
Q3 | 0.881 (0.607-1.279) | 0.932 (0.620-1.401) | 0.897 (0.591-1.360) |
dNLR | |||
Q1 | Ref. | Ref. | Ref. |
Q2 | 1.206 (0.832-1.750) | 1.085 (0.726-1.622) | 1.049 (0.697-1.576) |
Q3 | 0.916 (0.631-1.329) | 0.933 (0.623-1.399) | 0.887 (0.586-1.343) |
SII | |||
Q1 | Ref. | Ref. | Ref. |
Q2 | 0.843 (0.581-1.222) | 0.780 (0.521-1.165) | 0.767 (0.510-1.150) |
Q3 | 0.898 (0.620-1.301) | 0.967 (0.646-1.446) | 0.932 (0.618-1.405) |
TyG | |||
Q1 | Ref. | Ref. | Ref. |
Q2 | 1.756 (1.181-2.623) | 1.817 (1.179-2.815) | 1.871 (1.206-2.919) |
Q3 | 3.131 (2.136-4.624) | 2.621 (1.730-3.999) | 2.704 (1.750-4.206) |
TyG-BMI | |||
Q1 | Ref. | Ref. | Ref. |
Q2 | 2.495 (1.666-3.769) | 2.575 (1.710-3.913) | 2.584 (1.708-3.944) |
Q3 | 8.189 (5.400-12.603) | 8.300 (5.438-12.860) | 7.946 (5.138-12.480) |
OR, odds ratio; CI, confidence interval; NLR, neutrophil-to-lymphocyte ratio; dNLR, derived neutrophil-to-lymphocyte ratio; SII, systemic immune inflammation index; TyG, triglyceride-glucose; TyG-BMI, triglyceride glucose-body mass index; Ref, reference.
No covariates analyzed.
Covariates analyzed adjusted for age, gender, smoking, drinking, and BMI.
All covariates analyzed.